Literature DB >> 34408341

Does the Addition of Serum PAPP-A and β-hCG Improve the Predictive Value of Uterine Artery Pulsatility Index for Preeclampsia at 11-14 Weeks of Gestation? A Prospective Observational Study.

Zeba Khanam1, Pratima Mittal1, Jyotsna Suri1.   

Abstract

PURPOSE OF STUDY: To study the role of uterine artery Doppler pulsatility index (UtA-PI), serum pregnancy-associated plasma protein-A (PAPP-A) and free beta human chorionic gonadotropin (fβ-hCG) levels, individually and in combination with each other, at 11-14 weeks of gestation for prediction of preeclampsia (PE).
METHODS: In a prospective observational study, a total of 100 low-risk gravid females were recruited at 11-14-weeks of gestation. UtA-PI, PAPP-A and fβ-hCG levels were estimated. These women were followed up until delivery for the development of PE and gestational hypertension (GH).
RESULTS: The best individual marker for screening PE and GH was UtA-PI with ROC AUC (± standard error) = 0.934 ± 0.028, p < 0.0001. UtA-PI at a cutoff value of ≥ 2.8 (95th percentile) had 77.8% sensitivity, 98.9% specificity, 97.8% NPV and 87.5% PPV in detecting PE. PAPP-A (MoM) at a cutoff value of ≤ 0.27 (5th percentile) demonstrated 44.4% sensitivity, 95.6% specificity, 94.5% NPV and 50% PPV. fβ-hCG (MoM) at a cutoff value of ≤ 0.5 (5th percentile) had a specificity of 94.5%. Among the combined markers, UtA-PI along with PAPP-A estimation served best with a sensitivity and specificity of 44% and 100%, respectively. Addition of fβ-hCG to either UtA-PI or PAPP-A levels was not found sensitive for detecting PE but yielded 100% specificity and 96% NPV.
CONCLUSION: UtA-PI as a stand-alone test was found most useful for the prediction of PE. Addition of either or both of PAPP-A and fβ-hCG to UtA-PI did not improve the sensitivity of combined test with only a slight improvement in specificity and NPV. Their routine addition to UtA-PI studies is not recommended for prediction of PE at 11-14 weeks of gestation in low- and lower-middle-income countries (LMIC). © Federation of Obstetric & Gynecological Societies of India 2021.

Entities:  

Keywords:  Preeclampsia; Serum PAPP-A; Uterine artery pulsatility index; β-hCG

Year:  2021        PMID: 34408341      PMCID: PMC8310817          DOI: 10.1007/s13224-020-01420-7

Source DB:  PubMed          Journal:  J Obstet Gynaecol India        ISSN: 0975-6434


  26 in total

1.  First trimester maternal serum free beta human chorionic gonadotrophin and pregnancy associated plasma protein A as predictors of pregnancy complications.

Authors:  C Y Ong; A W Liao; K Spencer; S Munim; K H Nicolaides
Journal:  BJOG       Date:  2000-10       Impact factor: 6.531

2.  Prediction of pregnancy complications by first-trimester maternal serum PAPP-A and free beta-hCG and with second-trimester uterine artery Doppler.

Authors:  Kevin Spencer; Christina K H Yu; Nicholas J Cowans; Chineze Otigbah; Kypros H Nicolaides
Journal:  Prenat Diagn       Date:  2005-10       Impact factor: 3.050

3.  Maternal serum PAPP-A and free β-hCG at 12, 22 and 32 weeks' gestation in screening for pre-eclampsia.

Authors:  A Wright; L Guerra; M Pellegrino; D Wright; K H Nicolaides
Journal:  Ultrasound Obstet Gynecol       Date:  2016-05-02       Impact factor: 7.299

4.  Association of extreme first-trimester free human chorionic gonadotropin-beta, pregnancy-associated plasma protein A, and nuchal translucency with intrauterine growth restriction and other adverse pregnancy outcomes.

Authors:  David Krantz; Laura Goetzl; Joe Leigh Simpson; Elizabeth Thom; Julia Zachary; Terrence W Hallahan; Richard Silver; Eugene Pergament; Lawrence D Platt; Karen Filkins; Anthony Johnson; Maurice Mahoney; W Allen Hogge; R Douglas Wilson; Patrick Mohide; Douglas Hershey; Ronald Wapner
Journal:  Am J Obstet Gynecol       Date:  2004-10       Impact factor: 8.661

5.  First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: a population-based screening study (the FASTER Trial).

Authors:  Lorraine Dugoff; John C Hobbins; Fergal D Malone; T Flint Porter; David Luthy; Christine H Comstock; Gary Hankins; Richard L Berkowitz; Irwin Merkatz; Sabrina D Craigo; Ilan E Timor-Tritsch; Steven R Carr; Honor M Wolfe; John Vidaver; Mary E D'Alton
Journal:  Am J Obstet Gynecol       Date:  2004-10       Impact factor: 8.661

6.  Early pregnancy levels of pregnancy-associated plasma protein a and the risk of intrauterine growth restriction, premature birth, preeclampsia, and stillbirth.

Authors:  Gordon C S Smith; Emily J Stenhouse; Jennifer A Crossley; David A Aitken; Alan D Cameron; J Michael Connor
Journal:  J Clin Endocrinol Metab       Date:  2002-04       Impact factor: 5.958

7.  Decreased first trimester PAPP-A is a predictor of adverse pregnancy outcome.

Authors:  Yuval Yaron; Sigal Heifetz; Yifat Ochshorn; Ofer Lehavi; Avi Orr-Urtreger
Journal:  Prenat Diagn       Date:  2002-09       Impact factor: 3.050

8.  Predicting complications of pregnancy with first-trimester maternal serum free-betahCG, PAPP-A and inhibin-A.

Authors:  Natasa Tul; Stanko Pusenjak; Josko Osredkar; Kevin Spencer; Ziva Novak-Antolic
Journal:  Prenat Diagn       Date:  2003-12-15       Impact factor: 3.050

9.  Uterine artery Doppler at 11 + 0 to 13 + 6 weeks in the prediction of pre-eclampsia.

Authors:  W Plasencia; N Maiz; S Bonino; C Kaihura; K H Nicolaides
Journal:  Ultrasound Obstet Gynecol       Date:  2007-10       Impact factor: 7.299

Review 10.  Use of uterine artery Doppler ultrasonography to predict pre-eclampsia and intrauterine growth restriction: a systematic review and bivariable meta-analysis.

Authors:  Jeltsje S Cnossen; Rachel K Morris; Gerben ter Riet; Ben W J Mol; Joris A M van der Post; Arri Coomarasamy; Aeilko H Zwinderman; Stephen C Robson; Patrick J E Bindels; Jos Kleijnen; Khalid S Khan
Journal:  CMAJ       Date:  2008-03-11       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.